Simon J. Hall
YOU?
Author Swipe
View article: The Association Between Nurse Staffing and Conflict and Containment in Acute Mental Health Care: A Systematic Review
The Association Between Nurse Staffing and Conflict and Containment in Acute Mental Health Care: A Systematic Review Open
Conflict and containment are the most frequently reported incidents in acute mental health care settings. This systematic review seeks to examine and synthesise existing evidence on the association between nurse staffing levels, nursing sk…
View article: Generation Victoria (GenV): protocol for a longitudinal birth cohort of Victorian children and their parents
Generation Victoria (GenV): protocol for a longitudinal birth cohort of Victorian children and their parents Open
View article: Generation Victoria (GenV): Protocol for a longitudinal birth cohort of Victorian children and their parents
Generation Victoria (GenV): Protocol for a longitudinal birth cohort of Victorian children and their parents Open
Background In a world confronted with new and connected challenges, novel strategies are needed to help children and adults achieve their full potential, to predict, prevent and treat disease, and to achieve equity in services and outcomes…
View article: Generation Victoria (GenV): Creating a large consented longitudinal infrastructure for discovery and intervention research
Generation Victoria (GenV): Creating a large consented longitudinal infrastructure for discovery and intervention research Open
Designed to help solve complex problems facing children and adults, Generation Victoria is Australia’s largest-ever birth cohort, and the only such cohort mounted internationally during the COVID-19 pandemic. Here, we describe progress in …
View article: Analysis of England's incident and mental health nursing workforce data 2015–2022
Analysis of England's incident and mental health nursing workforce data 2015–2022 Open
Accessible Summary What is known on the subject? Mental health services report adverse incidents in different ways and the relationship between adverse incidents and the workforce is uncertain. In England, there are national datasets recor…
View article: The cognitive neuroscience of self‐awareness: Current framework, clinical implications, and future research directions
The cognitive neuroscience of self‐awareness: Current framework, clinical implications, and future research directions Open
Self‐awareness, the ability to take oneself as the object of awareness, has been an enigma for our species, with different answers to this question being provided by religion, philosophy, and, more recently, science. The current review aim…
View article: Could artificial intelligence write mental health nursing care plans?
Could artificial intelligence write mental health nursing care plans? Open
Accessible Summary What is Known on the Subject? Artificial intelligence (AI) is freely available, responds to very basic text input (such as a question) and can now create a wide range of outputs, communicating in many languages or art fo…
View article: Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium
Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium Open
Background Elicitation of patients’ preferences is an integral part of shared decision-making, the recommended approach for prostate cancer decision-making. Existing decision aids for this population often do not specifically focus on pati…
View article: Supplementary Materials and Methods, Tables ST1-13 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Supplementary Materials and Methods, Tables ST1-13 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome Open
Supplementary materials and Methods, Tables ST1-13. Table ST1: Baseline clinical characteristics of patients in IMPACT Table ST2: Baseline clinical characteristics of patients in ProACT. Table ST3: Increase in levels of IgG against candida…
View article: Data from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Data from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome Open
Purpose: Antitumor activity of cancer immunotherapies may elicit immune responses to nontargeted (secondary) tumor antigens, or antigen spread. We evaluated humoral antigen spread after treatment with sipuleucel-T, an immunotherapy …
View article: Supplementary Figure SF2 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Supplementary Figure SF2 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome Open
Supplementary Figure SF2. Shown in this figure are four Kaplan-Meier (KM) plots comparing the OS of patients in the sipuleucel-T arm of IMPACT with no IgG response at week 10 (IgG responses = 0) to patients with {greater than or equal to}1…
View article: Supplementary Figure SF1 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Supplementary Figure SF1 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome Open
Supplementary Figure SF1. Schematic of sipuleucel-T treatment doses (infusions) and serum collection time points in IMPACT and ProACT.
View article: Data from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Data from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome Open
Purpose: Antitumor activity of cancer immunotherapies may elicit immune responses to nontargeted (secondary) tumor antigens, or antigen spread. We evaluated humoral antigen spread after treatment with sipuleucel-T, an immunotherapy …
View article: Supplementary Figure SF1 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Supplementary Figure SF1 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome Open
Supplementary Figure SF1. Schematic of sipuleucel-T treatment doses (infusions) and serum collection time points in IMPACT and ProACT.
View article: Supplementary Figure SF2 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Supplementary Figure SF2 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome Open
Supplementary Figure SF2. Shown in this figure are four Kaplan-Meier (KM) plots comparing the OS of patients in the sipuleucel-T arm of IMPACT with no IgG response at week 10 (IgG responses = 0) to patients with {greater than or equal to}1…
View article: Supplementary Materials and Methods, Tables ST1-13 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Supplementary Materials and Methods, Tables ST1-13 from Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome Open
Supplementary materials and Methods, Tables ST1-13. Table ST1: Baseline clinical characteristics of patients in IMPACT Table ST2: Baseline clinical characteristics of patients in ProACT. Table ST3: Increase in levels of IgG against candida…
View article: Data from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
Data from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes Open
The genetic transfer of antigen receptors is a powerful approach to rapidly generate tumor-specific T lymphocytes. Unlike the physiologic T-cell receptor, chimeric antigen receptors (CARs) encompass immunoglobulin variable regions or recep…
View article: Supplementary Figure 1 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
Supplementary Figure 1 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes Open
Supplementary Figure 1 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
View article: Supplementary Figure 1 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
Supplementary Figure 1 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes Open
Supplementary Figure 1 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
View article: Supplementary Figure 2 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
Supplementary Figure 2 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes Open
Supplementary Figure 2 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
View article: Data from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
Data from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes Open
The genetic transfer of antigen receptors is a powerful approach to rapidly generate tumor-specific T lymphocytes. Unlike the physiologic T-cell receptor, chimeric antigen receptors (CARs) encompass immunoglobulin variable regions or recep…
View article: Supplementary Figure 2 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
Supplementary Figure 2 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes Open
Supplementary Figure 2 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
View article: Acceptability and feasibility of plasma phosphorylated‐tau181 in two memory services
Acceptability and feasibility of plasma phosphorylated‐tau181 in two memory services Open
Background Plasma phosphorylated‐tau181 (p‐tau181) represents a novel blood‐based biomarker of Alzheimer's disease pathology. We explored clinicians' experience of the utility of plasma p‐tau181 in Camden and Islington Memory Services. Met…
View article: Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium (Preprint)
Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium (Preprint) Open
BACKGROUND Elicitation of patients’ preferences is an integral part of shared decision-making, the recommended approach for prostate cancer decision-making. Existing decision aids for this population often do not specifically focus on pat…
View article: MP30-16 PSA DENSITY (PSAD) ALONE OR WITH MULTIPARAMETRIC MRI (MPMRI) IS ROBUST AT PREDICTING CLINICALLY SIGNIFICANT PROSTATE CANCER (CSPCA)
MP30-16 PSA DENSITY (PSAD) ALONE OR WITH MULTIPARAMETRIC MRI (MPMRI) IS ROBUST AT PREDICTING CLINICALLY SIGNIFICANT PROSTATE CANCER (CSPCA) Open
You have accessJournal of UrologyProstate Cancer: Detection & Screening III (MP30)1 Sep 2021MP30-16 PSA DENSITY (PSAD) ALONE OR WITH MULTIPARAMETRIC MRI (MPMRI) IS ROBUST AT PREDICTING CLINICALLY SIGNIFICANT PROSTATE CANCER (CSPCA) Shashan…
View article: Improved cancer coping from a web‐based intervention for prostate cancer survivors: A randomized controlled trial
Improved cancer coping from a web‐based intervention for prostate cancer survivors: A randomized controlled trial Open
Objectives Prostate cancer (PCa) survivors report poor physical functioning alongside negative psychological outcomes as they cope with treatment side effects and practical concerns after treatment completion. This study evaluated PROGRESS…
View article: Extracapsular extension on multiparametric magnetic resonance imaging better predicts pT3 disease at radical prostatectomy compared to perineural invasion on biopsy
Extracapsular extension on multiparametric magnetic resonance imaging better predicts pT3 disease at radical prostatectomy compared to perineural invasion on biopsy Open
Introduction: Risk assessment for non-organ-confined prostate cancer (PCa) is important in the surgical planning for radical prostatectomy (RP). Perineural invasion (PNI) on prostate biopsy has been associated with adverse pathological out…
View article: Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell Carcinomas
Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell Carcinomas Open
Introduction: For patients with localized node-negative (Stage I and II) clear cell renal cell carcinomas (ccRCC), current clinicopathological staging has limited predictive capability because of their low risk. Analyzing molecular …
View article: Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach
Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach Open
Background, context and purpose In spite of the mixed evidence for their impact, survivorship Care Plans (SCPs) are recommended to enhance quality of care for cancer survivors. Data on the feasibility of SCPs in bladder cancer (BC) is spar…
View article: Involving Patients in the Development and Evaluation of an Educational and Training Experiential Intervention (ETEI) to Improve Muscle Invasive Bladder Cancer Treatment Decision-making and Post-operative Self-care: a Mixed Methods Approach
Involving Patients in the Development and Evaluation of an Educational and Training Experiential Intervention (ETEI) to Improve Muscle Invasive Bladder Cancer Treatment Decision-making and Post-operative Self-care: a Mixed Methods Approach Open